Publications by authors named "S Lancrenon"
Article Synopsis
- Functional remission in schizophrenia, aimed at improving daily functioning, varies significantly in success rates, with around 15% to 51% of patients achieving it.
- A study followed 303 French schizophrenia patients on long-acting injectable treatment for a year, finding 45.1% reached functional remission while 55.1% achieved clinical remission; clinical remission greatly increased the chances of functional remission.
- Key factors influencing functional remission included the duration of the psychotic condition, family support, education level, employment status, initial functioning levels, and insight into their condition, underscoring the need for effective symptom management to enhance recovery.
Background: Clear guidance for successive antidepressant pharmacological treatments for non-responders in major depression is not well established.
Method: Based on the RAND/UCLA Appropriateness Method, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental developed expert consensus guidelines for the management of treatment-resistant depression. The expert guidelines combine scientific evidence and expert clinicians' opinions to produce recommendations for treatment-resistant depression.
Background: Recommendations for pharmacological treatments of major depression with specific comorbid psychiatric conditions are lacking.
Method: The French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental developed expert consensus guidelines for the management of depression based on the RAND/UCLA Appropriatneness Method. Recommendations for lines of treatment are provided by the scientific committee after data analysis and interpretation of the results of a survey of 36 psychiatrist experts in the field of major depression and its treatments.
Functional remission concerns only one third of schizophrenia patients who achieved symptomatic remission. We previously developed a scale devoted to functional remission, named the FROGS (Functional Remission Of General Schizophrenia). This instrument encompasses three clinically relevant dimensions.
View Article and Find Full Text PDF